Floatz logo

Stimotimagene Copolymerplasmid

Penile Neoplasms

Gene Surgery LLCPhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Penile Neoplasms cohort.

Asset / SponsorPhaseRating
Nivolumab
Instituto do Cancer do Estado de São Paulo
Phase 2B
Ganciclovir
Gene Surgery LLC
Phase 1CC

Same molecule, other indications

Stimotimagene Copolymerplasmid is also rated in:

vulvar neoplasmDormant
CC
Indicative ·
47 / 100
View asset →
anus neoplasmDormant
CC
Indicative ·
47 / 100
View asset →
head and neck squamous cell carcinomaDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →